ThermoGenesis Holdings Income Statement 2023-2009 | THMO

Brief overview of profit and loss at ThermoGenesis Holdings

This overview is based on financial performance over the past five years. ThermoGenesis Holdings reported revenue of 9.7 million dollars in 2018 and 9.4 million dollars by 2023. Across the full period, sales moved by −2.3%; the average annual rate was −0.5%. Sales changed only slightly and remained broadly flat.

Gross profit was 2.2 million dollars at the start and 1.9 million dollars at the end of the period (−11.9%). Direct costs broadly followed the top-line trend. The gross margin was 22.7% at the start and 20.4% at the end. The margin decline reflects a less favorable sales-and-cost structure.

EBITDA was −$42.9 million at the beginning and −$7.5 million at the end of the period (+82.6%). EBITDA expanded faster than the top line. EBITDA margin was −443.3% at the start and −79% at the end. Higher profitability strengthens the quality of operating growth.

Across the five years, the net result shifted from −$40.9 million to −$18.9 million. Losses became smaller, but the business remains unprofitable.

Conclusion

Signs of deterioration dominate the five-year picture. The financial profile benefits from improving net profitability and positive operating leverage. The main areas of concern are a softer top-line trend, pressure from direct costs and limited operating profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.